Clinical features of idiopathic restrictive cardiomyopathy: A retrospective multicenter cohort study over 2 decades

Jung Ae Hong1, Min-Seok Kim, Min-Su Cho

  • 1Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine Department of Internal Medicine, Seoul National University Hospital Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul Department of Cardiology, Translational Research Center on Aging, Chonnam National University Hospital, Gwangju Department of Internal Medicine, Wonju College of Medicine,Yonsei University, Wonju Department of Internal Medicine, Kangbuk Samsung Hospital, Seoul Department of Internal Medicine, CHA Bundang Medical Center, CHA University school of Medicine, Bundang Department of Cardiology, Sejong General Hospital Department of Cardiovascular Medicine, Gachon University Gil Medical Center, Incheon Department of Internal Medicine, Chungbuk National University School of Medicine, Cheongju, Korea.

Medicine
|September 9, 2017
PubMed

Insights

Idiopathic restrictive cardiomyopathy (RCMP) has a poor prognosis. Advanced tricuspid regurgitation and smaller left ventricular end-diastolic diameter predict mortality in these patients.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Clinical Research

Background:

  • Idiopathic restrictive cardiomyopathy (RCMP) diagnosis is challenging.
  • Limited understanding of RCMP clinical profile and outcomes exists.

Purpose of the Study:

  • To assess the clinical profile and outcomes of idiopathic RCMP.
  • To identify prognostic factors for mortality in idiopathic RCMP patients.

Main Methods:

  • Retrospective multicenter cohort study (10 Korean centers, 1990-2010).
  • Included 53 patients with idiopathic RCMP.
  • Multivariate Cox proportional hazards regression analyses for mortality predictors.

Main Results:

  • Median follow-up: 1.7 years; 32.1% mortality, 9.4% heart transplant.
  • 5-year survival rate: 64.4% ± 7.8%.
  • Predictors of mortality: moderate or severe tricuspid regurgitation (TR) (HR 32.55) and lower left ventricular end-diastolic diameter (LVEDD) (HR 0.85).

Conclusions:

  • Idiopathic RCMP demonstrates an unfavorable prognosis.
  • Advanced TR and reduced LVEDD are independent adverse predictors of mortality.
  • Further research into RCMP management and treatment is warranted.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
628
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
675
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
737
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
366